AstraZeneca PLC
06 June 2007
AstraZeneca CFO to join Goldman Sachs
AstraZeneca PLC announces the resignation of its Chief Financial Officer, Jon
Symonds, with effect from the end of July. Jon Symonds joined Zeneca in 1997 as
CFO after 17 years at KPMG. Within months of joining, he was involved in the
merger negotiations with Swedish pharmaceutical company, Astra. After
completion of the merger in 1998, Jon was appointed as CFO for AstraZeneca PLC.
'Jon has played a critical role in driving AstraZeneca to become one of the
leading, most focused and most successful pharmaceutical companies in the world.
On a personal level, I have worked closely with him for several years and have
valued his knowledge of the business, strategic thinking, and wise financial
counsel enormously,' said David Brennan, CEO.
Jon leaves AstraZeneca to join global investment banking, securities and
investment management firm, Goldman Sachs in mid September as a managing
director. His legacy at AstraZeneca includes a record of consistent strong
financial performance and a mature, well structured global Finance leadership
team.
Louis Schweitzer, Chairman, commented, 'I have the utmost respect for Jon's
personal and professional capabilities, he carries significant credit both for
the success of the merger itself and for AstraZeneca's sound financial
performance since 1998. I regret Jon's decision to leave AstraZeneca, however,
the move to Goldman Sachs represents an exciting career challenge for him and I
wish him every success with it.'
An external search is underway to identify a successor.
-Ends-
June 6th 2007
Media Enquiries:
Edel McCaffrey, Tel: +44 (0) 207 304 5034
Steve Brown, Tel: +44 (0) 207 304 5033
Investor Relations:
Mina Blair, Tel: +44 (0) 207 304 5084
Jonathan Hunt, Tel: +44 (0) 207 304 5087
Karl Hard, Tel: +44 (0) 207 304 5322
Jorgen Winroth, Tel: +1 (212) 579 0506
Ed Seage, Tel: +1 302 886 4065
Goldman Sachs:
Paul Kafka, Tel: +44(0) 207 774 4667
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.